CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.94
+0.11 (1.89%)
Aug 24, 2026, 4:00 PM EDT - Market closed
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $8.68 million as of August 24, 2026. Its market cap has increased by 133.15% in one year.
Market Cap
8.68M
Enterprise Value
-11.30M
1-Year Change
133.15%
Ranking
Category
Stock Price
$5.94
ChartMarket Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $8.68M, a decrease of -87.58%. That is a compound annual growth rate of -26.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 8.68M | 166.57% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 9.70M |
| Aprea Therapeutics | 9.56M |
| Skye Bioscience | 9.17M |
| Imunon | 9.01M |
| FibroBiologics | 8.86M |
| Soligenix | 8.80M |
| Immuron | 8.66M |
| Xenetic Biosciences | 8.55M |